Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...
Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...
Kite, a Gilead Sciences company, will share four posters that add to the growing body of evidence to support the clinical use of its chimeric antigen receptor (CAR) T-cell therapy portfolio, at the ...
Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now ...
Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...
7d
ZME Science on MSNGroundbreaking immunotherapy could finally treat devastating childhood brain tumorsA groundbreaking immunotherapy is showing unprecedented success against one of the deadliest childhood brain cancers — ...
The closing of the Offering is expected to occur on or about February 7, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the Offering are expected to be ...
Despite the powerful cancer-fighting capabilities of treatments based on CAR-T cells to fight a patient’s cancer, one key challenge is getting these treatments to more patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results